CLINICAL_TRIALS ClinicalTrials.gov record update

Post-marketing Surveillance (PMS) of GlaxoSmithKline Biologicals' 10-valent Pneumococcal Conjugate Vaccine (Synflorix™) When Administered to Healthy Infants and Children According to the Prescribing Information in Sri Lanka

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01803425
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:26.550302+00:00
Published At: 2013-09-09T00:00:00+00:00
Record Updated At: 2013-09-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Immunisation Against Streptococcus Pneumoniae"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-09-09"
protocolSection.identificationModule.nctId: "NCT01803425"
protocolSection.identificationModule.officialTitle: "Post-marketing Surveillance (PMS) of GlaxoSmithKline Biologicals\u0027 10-valent Pneumococcal Conjugate Vaccine (Synflorix\u2122) When Administered to Healthy Infants and Children According to the Prescribing Information in Sri Lanka"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.